Dr. Biswa Prasun Chatterji

PhD (2011), IIT Bombay

M.Tech Biotechnology (2002), Jadavpur University

M.Sc. Physiology (1999) University of Calcutta

B.Sc, Physiology Honours (1997), University of Calcutta

Professor, Faculty of Science, Assam down town University, (2022-till date)

Associate Professor in School of Engineering, Ajeenkya DY Patil University, Pune, India (2017-2022)

Assistant Professor in PG Department of Biotechnology at St.Xavier’s College Mumbai,India (2012-2017)

Analyst in Dolcera ITES Pvt Ltd, Hyderabad,India (2011-2012)

Research Associate in the R&D Division of Maharashtra Hybrid Seeds Company Ltd (MAHYCO), Jalna, Maharashtra, India (2005-2006)

Lecturer in Biotechnology at Haldia Institute of Technology, Haldia, West Bengal, under West Bengal University of Technology,India (2004-2005)

Anticancer Drug discovery - microtubule targeted drug molecules

Xanthan Fermentation

Global Mental Health 

Publications

Book Chapter

1. Needa Nasir, Riddhi Bhavsar and Chatterji BP (2017) Microtubules as Anticancer Drug Target in an e-book “Topics in Anti-Cancer Research", pg 31-74, Volume 6, 2017

: Bentham Science Publishers; (Invited book chapter)

1. Tanvi Kaku, Aiswarya Dash and Biswa P Chatterji (2018) Taxol to Nanotaxol: A Journey Towards Enhanced Drug Delivery. Topics in Anti-Cancer Research. vol 7,pg 1-23 Bentham Science Publishers; ( Invited book chapter)

Papers in International Journals

Research

1. Sujya Loying, Debanjan Roy, Jyotismita Sarma, Longpok Longkumer, Titus Datta Borah and Biswa Prasun Chatterji. Production of Xanthan gum using Food and Beverage waste and potential use of Xanthan as an agar substitute. Annals of Multidisciplinary Research, Innovation and Technology (AMRIT), 3(2), 2024, 85-97
2. Rahul Dey, Shrutimoyee Hazarika, Rajiv Chetia, Biswa Prasun Chatterji. Production of Xanthan Gum from Inedible Parts of Broccoli and Cauliflower. Environmental Research, Engineering and Management. (2024) vol 80, no.2, pp17-23
3. Rajiv Chetia, Bhriganka Bharadwaj, Rahul De and Biswa Prasun Chatterji. The Production of Xanthan from Brewer’s Spent Grain. Microbiology and Biotechnology Letters. (2023), vol 51(4); pp1-8
4. Rashid A, Naaz A, Rai A, Chatterji BP, Panda D.(2019) Inhibition of polo-like kinase 1 suppresses microtubule dynamics in MCF-7 cells. Mol Cell Biochem. 2019 Nov 28. doi: 10.1007/s11010-019-03664-y. [Epub ahead of print] Impact factor 3.39
5. Rai A, Kapoor S, Singh S, Chatterji BP, Panda D.(2015) Transcription factor NF-κB associates with microtubules and stimulates apoptosis in response to suppression of

microtubule dynamics in MCF-7 cells. Biochem Pharmacol. 93(3):277-89 Impact factor

: 5.85

1. Chakraborti, Soumyananda; Chakravarty, Devlina; Gupta, Suvroma; Chatterji, Biswaprasun; Dhar, Gopa; Poddar, Asim; Panda, Dulal; Chakrabarti, Pinak; Ghosh Dastidar, Shubhra; Bhattacharyya, Bhabatarak. (2012) Discrimination of ligands of different flexibility resulting from the plasticity of the binding site in tubulin. Biochemistry. 51(36):7138-48 Impact factor : 2.93
2. Naik PK, Chatterji BP, Vangapandu SN, Aneja R, Chandra R, Kanteveri S, Joshi HC. (2011) Rational design, synthesis and biological evaluations of amino-noscapine: a high affinity tubulin-binding noscapinoid. J Comput Aided Mol Des. 25 (5):443-54. Impact factor: 3.686
3. Chatterji BP, Banerjee M, Singh P, Panda D. (2010) HMBA depolymerizes microtubules, activates mitotic checkpoints and induces mitotic block in MCF-7 cells by binding at the colchicine site in tubulin. Biochem Pharmacol. 80(1):50-61. Impact factor : 5.85

Review

1. Snehal Mangaonkar, Sangeeta Nath, Biswa Prasun Chatterji. Microtubule Dynamics in Cancer Metastasis: Harnessing the underappreciated potential for therapeutic Interventions . Pharmacology & Therapeutics,263 (2024) 108726. Impact factor 12
2. Dipsikha Bordoloi, Nishita Acharjya and Dr Biswa Prasun Chatterji. Plastic Degrading Enzymes and Microbes. Indian Journal of Natural Sciences (2024) vol 15, issue 83, pp-72126-31
3. DUARAH R, KAKATI KS, AND CHATTERJI BP. A REVIEW ON THERAPEUTIC POTENTIAL OF NIMBOLIDE IN CANCER: MECHANISMS OF ACTION AND PRECLINICAL EVIDENCE. Annals of Multidisciplinary Research, Innovation and Technology (AMRIT), (2024) 3(1), 2024, 31-36.
4. Rahul De and Biswa Prasun Chatterji. Sources And Methods Of Manufacturing Xanthan By Fermentation Of Various Carbon Sources. Biotechnology Progress.2023 https://doi.org/10.1002/btpr.3379  Impact factor 2.9
5. Roza Parveen, Divya Harihar, Chatterji Biswa Prasun. RECENT HDAC INHIBITORS IN CANCER THERAPY. Cancer. 2023. http://doi.org/10.1002/cncr.34974  Impact factor 6.2
6. Swati Vatsya, Roza Parveen and Biswa Prasun Chatterji (2021) Toxicology of Nanoparticles in Drug Delivery. Current Pathobiology Reports. 9, 133–144 Impact factor 2.29
7. De Souza, C., Lindstrom, A.R., Ma, Z. and Chatterji, B.P., 2020. Nanomaterials as potential transporters of HDAC inhibitors. Medicine in Drug Discovery, p.100040.Impact factor 2.6
8. Biswa P. Chatterji, Godiwala Mehvash, Sunder Roma (2018) Ocular Stem Cells to Treat Retinal and Corneal Disorders. The Open Stem Cell Journal. 5:31-46 Impact Factor 1.0
9. De.O and Chatterji BP (2017) Marine microtubule targeting anticancer drugs. Recent Patents in Anticancer Drug Discovery. Vol 12, Issue 1, 102-127 Impact factor: 2.95
10. Agrawal M and Chatterji BP (2015) Patented small molecules used for reprogramming.

Current Regenerative Medicine, 5(2): 152-163.

1. DeSouza Cristabelle and Chatterji BP (2015) HDAC Inhibitors as Novel Anti-Cancer Therapeutics. Recent Patents on Anti-Cancer Drug Discovery. 10(2);145-162 Impact factor: 4.16
2. Srinivasan K and Chatterji BP (2014) Advances in cancer stem cells therapy: targets and treatments. Recent Patents in Regenerative Medicine. 4:79-93
3. Bhargava S and Chatterji BP (2014) Tubulin as Vaccine Target. Intellectual Property Rights Open Access. 2:124, impact factor 0.211
4. Chatterji BP, Jindal B, Srivastava S, Panda D. (2011) Microtubules as antifungal and antiparasitic drug targets. Expert Opin Ther Pat. 21(2):167-86. Impact factor: 4.29
5. Chatterji BP. (2010) On the discovery of the nature of cholera toxin in India. Vesalius. 16(1):16-8. SJR: 0.1

Correspondence

1. Chatterji BP. (2010) PhD: time and effort invested foster scientific maturity. Nature.

464(7290):831. Impact factor: 50.5

1. Chatterji BP (2014) India: Research Split harmed Universities. Nature 509:164 Impact factor: 50.5
2. Chatterji,BP (2017) PhD Jobs: explore Posts Abroad. Nature. 551:440 Impact factor 50.5
3. Chatterji,BP (2017) Ingenious solutions sparked by a crisis. Nature. 548:281 Impact factor 50.5
4. Sinha Debasmita and Chatterji Biswa Prasun (2021) India needs rigorously tested, culturally adapted cognitive behavioural therapy. Lancet Psychiatry, VOLUME 8, ISSUE 5, P361-362 Impact Factor 30.8
5. Ghosh Madhurima & Chatterji Biswa Prasun. (2020) Mental health insurance in India after COVID-19. Lancet Psychiatry, VOLUME 7, ISSUE 12, P1016-1017. Impact factor 30.8
6. Ghosh Madhurima & Chatterji Biswa Prasun. (2025) What to do when there is no Psychiatrist. NATURE, 637; pg 34 . Impact factor 50.5
7. Chatterji BP. Remembering India's pioneer in life-saving cholera treatment. Nature. 2022 Nov;611(7936):449 Impact factor 69.5

Conference Proceedings

1. 1. Dr. Biswa Prasun Chatterji*, Dr. Ms. Vivien Amonkar, Asha Jose, Dency Almeida, Karan Acharya Needa Nasir, Oindrila De, Rachel Agera and Ria Darne. (2016) Utility of Xanthan Gum Produced from Agro Food Waste. Proceedings of the India International science Festival –Young Scientists’ Meet; Department of Science & technology, Govt of India-Dec 4-8, 2015. Paper code: waste 23
   2. No patents

Won a 2 nd Prize for an oral presentation in Waste to Wealth section of India International Science Festival (IISF) 2015 at IIT Delhi between 4th and 8th Dec 2015 on “Utility of Xanthan Gum from Agro Food Waste”

Editorial Board Member of International Journal of Advance Study and Research Work (ISSN:2581-5997) Editorial Board Member of Global Research and Development Journal For Engineering (ISSN: 2455-5703)